Search Results - kathryn+miranda

2 Results

Sort By:

Immune CB1 Activation for Obesity Therapy

Reference #: 01478 The University of South Carolina is offering licensing opportunities for Immune CB1 activation for obesity therapy Background: The endocannabinoid system regulates various physiological processes such as inflammation and metabolism, and is comprised of cannabinoid receptors, CB1 and CB2, as well as their ligands called endocannabinoids....

Published: 11/29/2023 | Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Kathryn Miranda

Keywords(s): anti-inflammatory pharma, cannabinoids, CB1, inflammation, metabolic syndrome, Obesity, weight loss

Category(s): Health Sciences, Biomedical and Life Sciences

MicroRNA-30 in Therapy/Prevention of Inflammation, Obesity, and Metabolic Syndrome

Reference #1298The University of South Carolina is offering licensing opportunities for the use of MicroRNA-30 in Therapy/Prevention of Inflammation, Obesity, and Metabolic Syndrome.Background:Obesity is a global health issue that promotes risk for cardiometabolic diseases and some cancers. During obesity, adipose tissue macrophages (ATM) drive chronic...

Published: 5/27/2021 | Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Kathryn Miranda

Keywords(s):

Category(s): Biomedical and Life Sciences, Health Sciences